Recent data from VentureSource (we noted in our post on the medtech impact) show the decline in venture capital financing in 3Q 2009. There is, of course, a natural outcome that can be expected when there are well established medtech businesses with existing product lines (and cash flows) but seeking growth, while there simultaneously exist [...]
Signs that VC investment are at a six-year low came out of a recent Dow Jones VentureSource report. However, as one would expect, medical technology has fared better than the average for aggregate VC investment, with medtech drawing investment in recent months in excess of $400 million per month (see medtech financings by month, 2009). [...]
Third quarter 2009 financing results from Abbott and Baxter were made public this week. Baxter’s 3Q profit rose 12%. Abbott Labs’ 3Q profit rose 37% (coming at the expense of Medtronic in a patent dispute settlement). Boston Scientific’s 2Q profit at mid-year were up 61%. Meanwhile, smaller medtech companies (see WSJ’s Turning out the Lights) [...]
Below is a brief profile of Adhezion Biomedical, LLC, one of the companies active in the surgical sealants and glues market and profiled in the MedMarket Diligence report #S175. We occasionally highlight companies whose products, in our opinion, are poised to make an impact on medtech markets. Founded in 2001, Adhezion Biomedical (formerly Spartan Medical [...]
Back in July, we looked at the medical technology industry which, like all industries, was facing the effects of a lingering recession. While we have since seen that the recession has ended (by its pure definition being two or more quarters of decline in GDP), we know that this is not synonymous with a spike [...]
With medtech investments in July and August each at over $400 million, I had hopes (expectations?) that September would continue the trend, but through Sept. 30, medtech financings for the month totaled "only" $328 million. Of course, this is still a healthy amount, especially considering that September investment tends to be lower on a relative [...]
Endosense, Inc., has raised $36 million in a Series B financing (catheter ablation of cardiac arrhythmias) Athena Feminine Technologies has raised $2 million in a Series A financing (pelvic floor electrical stimulation for treatment of urinary incontinence) ValenTx, Inc., has raised $22 million in Series B financing (minimally invasive treatment of obesity) LifeWave Hi-Tech [...]
Venture capital still a big deal for the US economy, study says September 16, 2009 | Anthony Ha | View commentsComments Venture capital remained crucial to national economic growth over the last two years, according to a new study conducted by IHS Global Insight and commissioned by the National Venture Capital Association. I doubt many [...]
Arguably a slow start to September’s medtech financings, but I nonetheless expect it to pick up during the month, if not to the $400+ million month financings of July and August. Endosense, Inc., has raised $36 million in a Series B financing (catheter ablation of cardiac arrhythmias) Athena Feminine Technologies has raised $2 million in [...]
The aggregate amount of medtech investment, after taking a hit early this year from a pull back by venture capital, is now on the rise, with two months each of $400+ million investment. Investments and other financings over the first eight months of 2009 in medical device technologies as well as those that are complementary [...]
Contact:
